Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: News

Thanks for that heads-up. The fact that an Ivy League university is part of the agreement lends the whole business a certain credence... just so long as Dartmouth College doesn't delve too deeply into board member histories.

Another two years to a full license agreement. Could be a long slog but having waited fifteen years I can wait a little longer.

Share
New Message
Please login to post a reply